Erythromycin Lactobionate

Erythromycin Lactobionate, a form of the antibiotic erythromycin, is being studied in clinical trials for its effects on gastric motility and potential applications in managing diabetes. These trials aim to better understand how this drug influences stomach contractions, hunger sensations, and blood sugar levels. The research could lead to improved treatments for gastrointestinal disorders and diabetes management.

Table of Contents

What is Erythromycin Lactobionate?

Erythromycin Lactobionate is a form of the antibiotic erythromycin that is used for intravenous (IV) administration. It is also known by the brand name Erythrocin™ Lactobionate-IV[3]. This medication belongs to a class of drugs called macrolide antibiotics, which are commonly used to treat various bacterial infections.

Uses of Erythromycin Lactobionate

While erythromycin is primarily known as an antibiotic, research has shown that it has additional beneficial effects on the digestive system. Here are some of the uses being studied:

  • Gastric motility enhancement: Erythromycin Lactobionate is being investigated for its ability to stimulate gastric motility, which is the movement of food through the stomach and intestines. It acts as a gastroprokinetic agent, meaning it can enhance the contractions of the stomach[1].
  • Hunger and food intake regulation: Some studies are exploring how erythromycin affects hunger sensations and food intake. It may influence the stomach’s contractions, which are associated with feelings of hunger[2].
  • Gastric emptying in diabetes: Researchers are investigating the relationship between gastric emptying (how quickly food leaves the stomach) and blood sugar levels in people with Type 1 diabetes. Erythromycin is being used in these studies to manipulate gastric emptying rates[3].

How Erythromycin Lactobionate Works

Erythromycin Lactobionate works in two main ways:

  1. As an antibiotic: It fights bacterial infections by preventing bacteria from producing proteins that are essential for their growth and reproduction.
  2. As a gastroprokinetic agent: Erythromycin can stimulate contractions in the stomach and intestines. It does this by activating motilin receptors. Motilin is a hormone that naturally regulates the digestive system’s movement[2].

Administration and Dosage

Erythromycin Lactobionate is typically administered intravenously (through a vein). The dosage can vary depending on the specific condition being treated or studied. In research settings, some common dosages include:

  • 200 mg infused over 20 minutes[1]
  • 40 mg infused over 20 minutes[2]
  • 2-3 mg per kilogram of body weight, given as an initial bolus followed by an infusion[3]

It’s important to note that these dosages are used in controlled research settings and may differ from typical clinical use. Always follow your healthcare provider’s instructions when taking any medication.

Potential Side Effects

While the studies mentioned don’t specifically discuss side effects, it’s important to be aware that all medications can have potential side effects. Common side effects of erythromycin can include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Changes in heart rhythm (in rare cases)

Always discuss potential side effects with your healthcare provider before starting any new medication.

Ongoing Research

Several clinical trials are currently investigating various aspects of Erythromycin Lactobionate:

  • VIPUN Gastric Monitoring System: This study is examining how erythromycin affects gastric motility and how well a new monitoring system can detect these changes[1].
  • Hunger and food intake: Researchers are studying how erythromycin-induced stomach contractions relate to hunger sensations and food intake[2].
  • Diabetes and gastric emptying: This study is exploring how changes in gastric emptying (influenced by erythromycin) affect blood sugar levels in people with Type 1 diabetes[3].

These ongoing studies may lead to new uses for erythromycin in managing digestive disorders and potentially in diabetes care. However, it’s important to remember that research results take time to be verified and implemented in clinical practice.

Aspect Details
Main Focus Effects of Erythromycin Lactobionate on gastric motility and potential applications in diabetes management
Key Studies 1. VIPUN Gastric Monitoring System in Erythromycin Model
2. Effect on Hunger and Food Intake
3. Relationship between Gastric Emptying and Glycemic Variability in Type 1 Diabetes
Primary Outcomes 1. Gastric Balloon Motility Index
2. Changes in hunger ratings
3. Relationship between gastric emptying and glycemia
Methods Used 1. High-resolution manometry
2. Visual analog scales for hunger ratings
3. 13C-Spirulina breath tests for gastric emptying
4. Continuous glucose monitoring
Potential Applications 1. Improved understanding of gastric motility
2. Better management of blood sugar levels in diabetes
3. Possible new treatments for gastrointestinal disorders

Ongoing Clinical Trials on Erythromycin Lactobionate

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    3 1 1 1
    Belgium Croatia Czechia Estonia France Germany +7
  • Study on Erythromycin Lactobionate for Improving Gastric Emptying in Stroke Patients Needing Mechanical Thrombectomy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Gastric Motility: The movement of food through the stomach and intestines. It refers to the contraction of muscles in the gastrointestinal tract that mix and propel food during digestion.
  • Gastroprokinetic: A type of drug that enhances coordinated contractions of the stomach and intestines, potentially speeding up the rate at which the stomach empties its contents into the small intestine.
  • Migrating Motor Complex (MMC): A cyclic pattern of electrical and motor activity in the stomach and small intestine that occurs between meals. It consists of three phases and is thought to be involved in hunger sensations.
  • Continuous Glucose Monitoring (CGM): A method to track glucose levels throughout the day and night. CGM systems take glucose measurements at regular intervals and can help identify trends in glucose levels.
  • Glycemic Variability: The degree to which a person's blood glucose levels fluctuate throughout the day. High variability can be associated with complications in diabetes.
  • 13C-Spirulina Breath Test: A non-invasive test used to measure the rate of gastric emptying. Patients consume a meal containing 13C-labeled spirulina, and the amount of 13C in their breath over time indicates how quickly the stomach is emptying.

References

  1. https://clinicaltrials.gov/study/NCT04066231
  2. https://clinicaltrials.gov/study/NCT02633579
  3. https://clinicaltrials.gov/study/NCT02755064